M. Raghunath et al., Transglutaminase activity in the eye: Cross-linking in epithelia and connective tissue structures, INV OPHTH V, 40(12), 1999, pp. 2780-2787
PURPOSE. To assess the distribution of transglutaminase (TGase) activity in
ocular tissues and the target structures for cross-linking.
METHODS. Cryosections from human and cynomolgus monkey eyes were incubated
with the biotinylated amine donor substrate cadaverine (biot), which was su
bsequently visualized with streptavidin-peroxidase. Confocal laser scanning
was used to colocalize biotC and fibrillin, a major component of elastic m
icrofibrils and the zonular fibers in particular. Cryosections and isolated
bovine zonules were treated with purified TGase 2 and biotC. The distribut
ion of different TGases (1, 2, 3, and factor; XIII) was confirmed immunohis
tochemically.
RESULTS. Virtually all ocular tissues showed TGase activity with a remarkab
le preponderance for the ciliary body, zonular fibers, and blued vessel wal
ls. Confocal laser scanning revealed fibrillin-containing microfibrils as a
major target for TGase activity, in particular the ciliary zonules. Cornea
l epithelium and basement membrane showed a TGase cross-linking pattern sim
ilar to sl;in. Treatment of cryosections and isolated bovine zonular fibers
with purified TGase 2 led to additional incorporation of biotC into extrac
ellular matrix, particularly zonular fibers. The immunohistochemically pred
ominant TGase 2 was associated with epithelia and particularly with connect
ive tissue fibers. TGase I was restricted to the corneal epithelium, wherea
s factor XIII was found to be associated only with blood vessels. TGase 3 w
as absent.
CONCLUSIONS. TGase 2 appears to be an important cross-linker and thus stabi
lizer of ocular connective tissue. In particular, the zonular fibers are 3
major target for TGase 2. This is of relevance in hereditary microfibrillop
athies such as Marfan syndrome, which exhibits distinct ocular manifestatio
ns such as elongated bulbus, retinal detachment, and subluxation of the len
s. Purified or recombinant TGase might be of therapeutic use in the future.